baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Overview

Chart

News

HDAX P-IN./ DE0008469016

HDAX

23/08/2024 17:50:00	Chg. +78.37	Open	High	Low	Previous Close
9,832.54XXP	+0.80%	9,776.03	9,847.55	9,769.72	9,754.17
9,832.54XXP	+0.80%	9,776.03	9,847.55	9,769.72	9,754.17

GlobeNewswire 02/05 Iktos announces the appointment of Roman Fleck as Chairman of the Board

GlobeNewswire 13/12/2016 MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or...

GlobeNewswire 06/12/2016 MorphoSys Presents Updated Clinical Data for Blood Cancer Candidate MOR208 in NHL and CLL at ASH 201...

GlobeNewswire 06/12/2016 MorphoSys Presents Updated Clinical Results for Anti-CD38 Antibody MOR202 at ASH 2016

GlobeNewswire 29/11/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...

GlobeNewswire 28/11/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted a Marketing Authorisation Application Fo...

GlobeNewswire 25/11/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...

GlobeNewswire 22/11/2016 Correction of a release from 21.11.2016, 18:05 CET - MorphoSys AG: Publication pursuant to §26 sect....

GlobeNewswire 21/11/2016 MorphoSys AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the a...

GlobeNewswire 21/11/2016 MorphoSys AG: Notification of managers`transactions according to article 19 MAR

GlobeNewswire 17/11/2016 MorphoSys Announces That Its Licensee Janssen Has Submitted Biologics License Application For Guselk...

GlobeNewswire 17/11/2016 MorphoSys AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of...

GlobeNewswire 15/11/2016 MorphoSys Raises EUR 115 million in Private Placement

GlobeNewswire 15/11/2016 Ad hoc: MorphoSys Raises EUR 115 million in Private Placement

GlobeNewswire 15/11/2016 MorphoSys to Raise Capital via a Private Placement of New Shares

GlobeNewswire 15/11/2016 Ad hoc: MorphoSys to Raise Capital via a Private Placement of New Shares

GlobeNewswire 15/11/2016 MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in ...

GlobeNewswire 14/11/2016 MorphoSys to Present at Upcoming Investor Conferences

GlobeNewswire 08/11/2016 Anke Linnartz joins MorphoSys as Head of Corporate Communications and Investor Relations

GlobeNewswire 07/11/2016 MorphoSys AG Reports Results for the First Nine Months of 2016

GlobeNewswire 03/11/2016 MorphoSys Announces Presentations of Clinical Data at Upcoming American Society of Hematology (ASH) ...

GlobeNewswire 02/11/2016 MorphoSys and LEO Pharma Enter into Strategic Alliance to Develop Therapeutic Antibodies in Dermatol...

GlobeNewswire 28/10/2016 MorphoSys to Host Q3 2016 Conference Call on November 7, 2016

GlobeNewswire 20/10/2016 MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial with Novel Cancer Antibody

HDAX P-IN./ DE0008469016

If you wish to receive reply to your feedback, please provide your email address.